How to Explain TR Categories to Your Patient
The TR (Thyroid Reporting) system is a scoring method that helps us determine how suspicious your thyroid nodule looks on ultrasound and whether it needs a biopsy or just monitoring.
The Five TR Categories Explained
The ACR TI-RADS system classifies thyroid nodules into five categories based on their ultrasound appearance 1:
TR1 (Benign) - 0 points
- What it means: The nodule looks completely benign
- What we do: No biopsy needed, no follow-up required
- Patient-friendly explanation: "Your nodule looks normal and safe. We don't need to do anything."
TR2 (Not Suspicious) - 2 points
- What it means: The nodule has minimal concerning features
- What we do: Only biopsy if it grows to 2.5 cm or larger
- Patient-friendly explanation: "Your nodule looks very unlikely to be cancer. We'll only check it with a needle if it gets quite large (about 1 inch)."
TR3 (Mildly Suspicious) - 3 points
- What it means: The nodule has some mildly concerning features
- What we do: No biopsy recommended; follow with ultrasound if ≥1 cm
- Patient-friendly explanation: "Your nodule has a few features that make us want to watch it, but it's still probably benign. We'll monitor it with ultrasound."
TR4 (Moderately Suspicious) - 4-6 points
- What it means: The nodule has several concerning features
- What we do: Biopsy if ≥1.5 cm; follow with ultrasound if ≥0.5 cm
- Patient-friendly explanation: "Your nodule has features that make us more concerned. If it's larger than half an inch, we'll do a needle biopsy to check it."
TR5 (Highly Suspicious) - 7+ points
- What it means: The nodule has many features suggesting possible cancer
- What we do: Biopsy if ≥1 cm
- Patient-friendly explanation: "Your nodule has features that look more suspicious for cancer. If it's 1 cm or larger, we need to do a biopsy to know for sure."
How the Scoring Works
The system assigns points based on five ultrasound features 1:
- Composition (solid vs. cystic)
- Echogenicity (how bright or dark it appears)
- Shape (taller-than-wide is concerning)
- Margin (irregular edges are concerning)
- Calcifications (certain types are more suspicious)
The total points determine your TR category, which then guides whether you need a biopsy and at what size.
Important Context for Patients
Why Size Matters
Smaller nodules, even if they look suspicious, may not need immediate biopsy because most thyroid cancers grow slowly and small cancers rarely affect your health 1. The system is designed to avoid over-diagnosing and over-treating thyroid nodules that would never cause problems.
The Reality Check
- Most thyroid nodules are benign (70-80%) 2, 3
- Only 5-10% are actually malignant 3
- The TR system helps us avoid unnecessary biopsies while still catching cancers that matter 1
Common Pitfalls to Address
"Why aren't you biopsying my nodule if it looks suspicious?"
Explain that the ACR TI-RADS deliberately uses higher size thresholds to balance finding important cancers against the harm of biopsying and treating nodules that would never cause problems 1. Even highly suspicious nodules under 1 cm are usually monitored rather than biopsied.
"My nodule is growing - does that mean cancer?"
Most nodules remain stable in size regardless of TR category, and only about 25% show significant growth during follow-up 4. Growth alone doesn't mean cancer, but growth combined with changing ultrasound features increases concern 4.
"Can the category change?"
Yes - about 12.7% of nodules get upgraded and 3.9% get downgraded during follow-up as their appearance changes 4. This is why we do surveillance ultrasounds for certain categories.
What Happens Next
Based on your TR category and nodule size:
- TR1: Nothing needed
- TR2: Ultrasound monitoring if ≥1.5 cm
- TR3: Ultrasound monitoring if ≥1 cm
- TR4: Biopsy if ≥1.5 cm, ultrasound if 0.5-1.5 cm
- TR5: Biopsy if ≥1 cm
The TR system works best when combined with the biopsy results (Bethesda classification) to give us the complete picture 2. Both systems complement each other - ultrasound appearance (TR) tells us who needs a biopsy, and the biopsy (Bethesda) tells us what the cells actually look like.